These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 18513490

  • 1. Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1.
    Chung SS, Kim JH, Park HS, Choi HH, Lee KW, Cho YM, Lee HK, Park KS.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):713-8. PubMed ID: 18513490
    [Abstract] [Full Text] [Related]

  • 2. Sp1 mediates repression of the resistin gene by PPARgamma agonists in 3T3-L1 adipocytes.
    Chung SS, Choi HH, Cho YM, Lee HK, Park KS.
    Biochem Biophys Res Commun; 2006 Sep 15; 348(1):253-8. PubMed ID: 16876120
    [Abstract] [Full Text] [Related]

  • 3. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.
    Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE.
    Proc Natl Acad Sci U S A; 2001 Jun 05; 98(12):6611-6. PubMed ID: 11371615
    [Abstract] [Full Text] [Related]

  • 4. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J, Morales M, Caelles C.
    Diabetes; 2007 Jul 05; 56(7):1865-71. PubMed ID: 17416798
    [Abstract] [Full Text] [Related]

  • 5. O-GlcNAcylation of Sp1 interrupts Sp1 interaction with NF-Y.
    Lim K, Chang HI.
    Biochem Biophys Res Commun; 2009 May 08; 382(3):593-7. PubMed ID: 19302979
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D, Qi H, Gabriele S, Catalano S, Aquila S, Belmonte M, Andò S.
    Endocr Relat Cancer; 2008 Jun 08; 15(2):545-57. PubMed ID: 18509005
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS, Warburton P, O'Regan DJ, Ball SG, Turner NA, Porter KE.
    Clin Exp Pharmacol Physiol; 2009 May 08; 36(5-6):478-86. PubMed ID: 19673929
    [Abstract] [Full Text] [Related]

  • 9. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin.
    Walgren JL, Vincent TS, Schey KL, Buse MG.
    Am J Physiol Endocrinol Metab; 2003 Feb 08; 284(2):E424-34. PubMed ID: 12397027
    [Abstract] [Full Text] [Related]

  • 10. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM, Ma M, Too CK.
    J Cell Biochem; 2005 Oct 15; 96(3):579-88. PubMed ID: 16052526
    [Abstract] [Full Text] [Related]

  • 11. O-GlcNAc modification in diabetes and Alzheimer's disease.
    Dias WB, Hart GW.
    Mol Biosyst; 2007 Nov 15; 3(11):766-72. PubMed ID: 17940659
    [Abstract] [Full Text] [Related]

  • 12. Stress-induced expression of the p75 neurotrophin receptor is regulated by O-GlcNAcylation of the Sp1 transcription factor.
    Kommaddi RP, Dickson KM, Barker PA.
    J Neurochem; 2011 Feb 15; 116(3):396-405. PubMed ID: 21105874
    [Abstract] [Full Text] [Related]

  • 13. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S.
    Mol Pharmacol; 2008 Oct 15; 74(4):952-63. PubMed ID: 18599600
    [Abstract] [Full Text] [Related]

  • 14. O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon.
    Majumdar G, Harmon A, Candelaria R, Martinez-Hernandez A, Raghow R, Solomon SS.
    Am J Physiol Endocrinol Metab; 2003 Sep 15; 285(3):E584-91. PubMed ID: 12900380
    [Abstract] [Full Text] [Related]

  • 15. Altered O-GlcNAc modification and phosphorylation of mitochondrial proteins in myoblast cells exposed to high glucose.
    Gu Y, Ande SR, Mishra S.
    Arch Biochem Biophys; 2011 Jan 01; 505(1):98-104. PubMed ID: 20887712
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1.
    Deng T, Shan S, Li PP, Shen ZF, Lu XP, Cheng J, Ning ZQ.
    Endocrinology; 2006 Feb 01; 147(2):875-84. PubMed ID: 16269451
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells.
    Chung SS, Kim M, Youn BS, Lee NS, Park JW, Lee IK, Lee YS, Kim JB, Cho YM, Lee HK, Park KS.
    Mol Cell Biol; 2009 Jan 01; 29(1):20-30. PubMed ID: 18936159
    [Abstract] [Full Text] [Related]

  • 20. PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle.
    Remels AH, Langen RC, Gosker HR, Russell AP, Spaapen F, Voncken JW, Schrauwen P, Schols AM.
    Am J Physiol Endocrinol Metab; 2009 Jul 01; 297(1):E174-83. PubMed ID: 19417127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.